Jaguar Health, Inc. (JAGX)

Joanna Estrada
December 17, 2017

Press coverage about Jaguar Health (NASDAQ:JAGX) has trended positive recently, according to Accern Sentiment Analysis. That activity is comparable to their recent volume average trend of almost 2.72 million shares which they recorded over a period of three months. The stock fell -78.33 percent over the past six months. Its opening price on the last trading day was $0.12. The company has 100.79 Million shares outstanding and 100.09 Million shares were floated in market. The relative volume of the stock is 5.18.

Jaguar Health, Inc. analysts gave 0 buy-equivalent recommendations, 0 sells and 0 holds.

The stock has advanced 23.81% to a low over the previous 12 months and showed declining move -91.45% to a high over the same period.

According to Jaguar Health, Inc.'s latest 13F filing with the US Securities and Exchange Commission (SEC), institutional ownership is at 21.75%. (JAGX) performance during the last one year degraded -84.71 percent, while its year to date (YTD) performance showed a negative trend of -81.84 percent. Tracking the stock price in relation to moving averages as well as highs and lows for the year might assist with evaluating future stock performance. Net profit margin of the company was recorded at 0 percent, operating profit margin was 0 percent, while gross profit margin stands at 96.3 percent. It is very obvious that earnings are the most important factors to investors, thus analysts are most likely to place their bet on the P/E.

The most recent non open market insider trade was completed by LOUGHLIN MICHAEL J on 12/05/2017, and was a disposition of 600 shares with a final price of $0. In order for us to accurately measure profitability and return, we will be using the EBITDA margin and Return on Investment (ROI), which balances the difference in capital structure.

Moving averages are used as a strong indicator for technical stock analysis and it helps investors in figuring out where the stock has been and also helps in determining where it may be possibly heading. As for the shares, it has gone below the 20 days moving average and is now hovering within a distance of -5.07%. During last 3 month period, 248.11% of total institutional ownership has changed in the company shares. The consensus mean EPS for the current quarter is at $-0.07 derived from a total of 1 estimates from the analysts who have weighed in on projected earnings.

EPS Growth this year is 50.2 percent.

Annual EPS growth Past 5 years is 0 percent.

When a company is able to grow consistently in terms of earnings at a high compound rate have the highest likelihood of creating value for its shareholders over time. The company P/S (price to Sales) ratio is 7.28, P/B (price to Book) ratio is 0, while its P/C (price to Cash) ratio stands at 4.68. Jaguar Health earned a media sentiment score of 0.27 on Accern's scale.

ATR value of the company was 0.02 and Relative Strength Index (RSI) was 48.14. (JAGX), Week Volatility is 16.12%, whereas Month Volatility is at 12.32%.

The company last reported its quarterly results on 0. Analysts have a mean recommendation of 2.00 on this stock. Jaguar Health has a twelve month low of $0.10 and a twelve month high of $1.52.

There are 15 institutional holders with active positions, accounting for 10.49 million shares in total.

Other reports by Click Lancashire

Discuss This Article